Yucun Huang

Yucun Huang

Auto-generated profile, based on publicly available information

Yucun Huang

Guangdong Provincial People's Hospital, Jinwan Central Hospital of Zhuhai, Zhuhai, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
LJLupeng Ji
Lupeng Ji
YHYucun Huang
Yucun Huang
YZYi Zhang
Yi Zhang
APAnping Peng
Anping Peng
JQJilong Qin
Jilong Qin
YHYu Huang
Yu Huang
Background: Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. However, the molecular mechanism of NSCLC remains unknown. Accumulating data show that Rhotekin 2 (RTKN2) functions as a novel crucial regulator of diverse biological processes; however, its pathological role in NSCLC remains unclear. Methods: In this study, we investigated the function of RTKN2 in NSCLC. The expression of RTKN2 mRNA was analyzed in tumor tissues and paired adjacent tissues from patients by qRT-PCR. The role of RTKN2 in cell proliferation, apoptosis, migration, and invasion was investigated. The potential mechanisms were explored. Results: We found that the level of RTKN2 mRNA was up-regulated in NSCLC tissues and cell lines. RTKN2 knockout inhibited the proliferation of human NSCLC cell lines A549 via inducing apoptosis by increasing the level of Bax and decreasing the level of Bcl-2. Furthermore, silencing of RTKN2 reduced the migration and invasion of A549 cells through up-regulated matrix metalloproteinase-9 (MMP9) and MMP2 expression. Conclusion: These data suggest that RTKN2 may not only be a prognostic biomarker candidate but also provide a potential therapeutic target for NSCLC diagnosis and treatment.

12 December 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
DLDan Liu
Dan Liu
JZJingjing Zhao
Jingjing Zhao
LLLing Li
Ling Li
JWJie Wang
Jie Wang
CWChao Wang
Chao Wang
WCWujun Chen
Wujun Chen
CD73, an important metabolic and immune escape-promoting gene, catalyzes the hydrolysis of adenosine monophosphate (AMP) to adenosine (ADO). AMP has anti-inflammatory and vascular relaxant properties, while ADO has a strong immunosuppressive effect, suggesting that CD73 has pro-inflammatory and immune escape effects. However, CD73 also decreased proinflammatory reaction, suggesting that CD73 has a positive side to the body. Indeed, CD73 plays a protective role in diabetes, while with age, CD73 changes from anti-atherosclerosis to pro-atherosclerosis. The upregulation of CD73 with agents, including AGT-5, Aire-overexpressing DCs, Aspirin, BAFFR-Fc, CD4+ peptide, ICAs, IL-2 therapies, SAgAs, sCD73, stem cells, RAD51 inhibitor, TLR9 inhibitor, and VD, decreased diabetes and atherosclerosis development. However, the downregulation of CD73 with agents, including benzothiadiazine derivatives and CD73 siRNA, reduced atherosclerosis. Notably, many CD73 agents were investigated in clinical trials. However, no agents were used to treat diabetes and atherosclerosis. Most agents were CD73 inhibitors. Only FP-1201, a CD73 agonist, was investigated in clinical trials but its further development was discontinued. In addition, many lncRNAs, circRNAs, and genes are located at the same chromosomal location as CD73. In particular, circNT5E promoted CD73 expression. circNT5E may be a promising target for agent development. This mini-review focuses on the current state of knowledge of CD73 in diabetes, atherosclerosis, and its potential role in agent development.

22 February 2021 in Chinese Journal of Academic Radiology
Verified
Journal Article
Closed access
PDF file
YHYucun Huang
Yucun Huang
LXLiling Xie
Liling Xie
ZCZhi Cao
Zhi Cao
SLShaofan Lu
Shaofan Lu
SHShengfu Huang
Shengfu Huang

9 July 2021 in Chinese Journal of Academic Radiology
Verified
Journal Article
Closed access
PDF file
YHYucun Huang
Yucun Huang
LXLiling Xie
Liling Xie
ZCZhi Cao
Zhi Cao
SLShaofan Lu
Shaofan Lu
SHShengfu Huang
Shengfu Huang

25 March 2026 in Current Medical Imaging
Verified
Journal Article
Open access
WWWenhao Wu
Wenhao Wu
YHYiyin Hu
Yiyin Hu
DZDantian Zhu
Dantian Zhu
WLWei Li
Wei Li
WYWen Yu
Wen Yu
YFYijie Fang
Yijie Fang
Introduction: This study aimed to evaluate the impact of varying slice thickness on quantitative values using the Magnetic Resonance Image Compilation (MAGiC) sequence. Methods: In this retrospective study, 23 healthy subjects underwent the MAGiC sequence (at 3.0 T) with three slice thicknesses: 3 mm (TH3), 4 mm (TH4), and 5 mm (TH5). The T1, T2, and PD values were measured in various knee joint cartilage regions by two experienced radiologists, including the lateral femoral condyle (LFC), lateral tibial plateau (LTP), medial femoral condyle (MFC), medial tibial plateau (MTP), patella (PAT), and trochlea (TRO). The effects of varying slice thicknesses (TH4 vs. TH3 and TH5 vs. TH3) were analyzed using paired t-tests or Wilcoxon signed rank tests, with statistical significance set at P < 0.025. Intra-rater and inter-rater reliability were also assessed. Results: Measurements of T1, T2, and PD values demonstrated high intra- and inter-rater reliability. Minimal differences were observed across slice thicknesses for T1WI, T2WI, and PDWI images. T2 and PD values showed little variation, while T1 mapping revealed significant differences. T2 values were consistent across regions, except for the LFC. Discussion: TH4 and TH5 can replace TH3 for knee joint scanning while reducing scan time, with minimal differences in anatomical depiction across sequences. MAGiC technology significantly improves efficiency by acquiring quantitative data in a single scan, demonstrating stable T2 values unaffected by slice thickness, though T1 and PD values are thickness-dependent. This technique holds clinical value for cartilage injury assessment but requires further research on the applicability of multiplanar imaging. Conclusion: T2 values obtained with the MAGiC sequence are stable across TH3, TH4, and TH5, allowing for reliable cartilage T2 quantification using TH5 to reduce patient scan time.